Not a financial advice. Do your own research and have a happy trading.
possible buy opportunity at CRISPR, the pullback seems to be over, the company - the big leader among gene-editing pioneers - is extraordinary, the current capitalization of 12, B poae rises in the next max 5 years to 100B. Green resistance is the maximum reached by the company since it is listed.
possible buy opportunity at CRISPR, the pullback seems to be over, the company - the big leader among gene-editing pioneers - is extraordinary, the current capitalization of 12, B poae rises in the next max 5 years to 100B. Green resistance is the maximum reached by the company since it is listed.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。